Mango Sciences utilizes a data analytics platform to aggregate and analyze clinical data from underrepresented patient populations, enabling healthcare providers to access real-world evidence for precision medicine. The company addresses the lack of affordable and accessible individualized patient care in emerging markets by fostering partnerships with healthcare systems and life science companies.
Funding
Funding not disclosed
IVFounders
Product
Problem
Emerging markets often lack affordable and accessible individualized patient care due to underrepresentation in clinical data and life science research. This disparity limits healthcare providers' access to real-world evidence needed for precision medicine in these populations.
Solution
Mango Sciences provides a data analytics platform that aggregates and analyzes clinical data from underrepresented patient populations, enabling healthcare providers to access real-world evidence for precision medicine. By fostering partnerships with healthcare systems and life science companies in emerging markets, Mango Sciences aims to improve patient access to innovative treatments and data-driven insights. The platform simplifies complex patient data, facilitating collaboration between key healthcare stakeholders and promoting the delivery of high-quality care. This approach unlocks healthcare insights that enable better access and more innovative patient care.
Target Audience
The primary customers are healthcare providers seeking data-driven insights for improved patient care, life science companies aiming to expand into emerging markets, and financial institutions looking to invest in healthcare solutions.
Features
- Data aggregation and analysis from underrepresented patient populations.
- Real-world evidence generation for precision medicine applications.
- Partnerships with healthcare systems and life science companies in emerging markets.
- Advanced analytics to simplify complex patient data.
- Patient affordability and accessibility initiatives.